Search results
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 6 hours agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 16 hours agoLexicon Pharmaceuticals has chosen clinical trial solutions provider Medidata to help advance the ...
...Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...
FOX 5 San Diego· 7 days agoThe data will be presented in a poster at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) on June 2, 2024.
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 5 hours agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed...
New Drug Offers Hope for CPAP-Free Nights for Sleep Apnea
WebMD· 11 hours agoRoughly 30 million to 40 million people in the United States, and nearly a billion people worldwide, have sleep apnea. Closure of your upper airway is the hallmark of sleep apnea. Because they ...
Does Medicare Part D cover prescriptions for clinical trials?
Las Vegas Review-Journal· 9 hours agoExploring Part D and prescription drugs is one of the most important Medicare topics. Lincoln, you...
ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Investing.com· 2 days agoICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 1 day agoThis decision comes after recent consultations with the U.S. Food and Drug Administration (FDA) and...
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Pharmaceutical Technology via Yahoo Finance· 15 hours agoDCTs and hybrid digital trials are on the rise – and are driving new complexities in clinical trial...
J&J’s seltorexant meets all endpoints in Phase III MDD trial
Clinical Trials Arena via Yahoo Finance· 15 hours agoThe MDD therapeutics market is projected to grow to $9.6bn by 2029, driven by an increase in the...